BIOMAT Database Logo BIOMAT Database Logo

[Treatment of neoplastic hypercalcemia with ethane 1-hydroxy-1 diphosphonate in low dosage]. 1982

G Chabrier, and C Simon, and J L Schlienger, and M Imler

UI MeSH Term Description Entries
D008297 Male Males
D001984 Bronchial Neoplasms Tumors or cancer of the BRONCHI. Neoplasms, Bronchial,Bronchial Neoplasm,Neoplasm, Bronchial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006934 Hypercalcemia Abnormally high level of calcium in the blood. Milk-Alkali Syndrome,Hypercalcemias,Milk Alkali Syndrome,Syndrome, Milk-Alkali
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012968 Etidronic Acid A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover. EHDP,Ethanehydroxydiphosphonate,Etidronate,Etidronate Disodium,Sodium Etidronate,(1-hydroxyethylene)diphosphonic acid,(1-hydroxyethylene)diphosphonic acid, Tetrapotassium Salt,1,1-hydroxyethylenediphosphonate,1-Hydroxyethane-1,1-Diphosphonate,1-Hydroxyethylidene-1,1-Bisphosphonate,Dicalcium EHDP,Dicalcium Etidronate,Didronel,Disodium 1-Hydroxyethylene Diphosphonate,Disodium Etidronate,Ethanehydroxyphosphate,Etidronate, Tetrapotassium Salt,HEDP,HEDSPA,Hydroxyethanediphosphonate,Hydroxyethylidene Diphosphonic Acid,Phosphonic acid, (1-hydroxyethylidene)bis-, disodium salt,Xidifon,Xidiphon,Xydiphone,1 Hydroxyethane 1,1 Diphosphonate,1 Hydroxyethylidene 1,1 Bisphosphonate,1,1 hydroxyethylenediphosphonate,1-Hydroxyethylene Diphosphonate, Disodium,Diphosphonate, Disodium 1-Hydroxyethylene,Diphosphonic Acid, Hydroxyethylidene,Disodium 1 Hydroxyethylene Diphosphonate,EHDP, Dicalcium,Etidronate, Dicalcium,Etidronate, Disodium,Etidronate, Sodium,Salt Etidronate, Tetrapotassium,Tetrapotassium Salt Etidronate

Related Publications

G Chabrier, and C Simon, and J L Schlienger, and M Imler
[Treatment of Paget's disease of bone with ethane-1 hydroxy-1, 1 diphosphonate at low dosage (author's transl)].
November 1980, La Nouvelle presse medicale,
G Chabrier, and C Simon, and J L Schlienger, and M Imler
[Treatment of Paget's disease with 1-ethane-1-hydroxy-1-diphosphonate].
February 1982, Revue du rhumatisme et des maladies osteo-articulaires,
G Chabrier, and C Simon, and J L Schlienger, and M Imler
Treatment of Paget's disease of bone with ethane-1, hydroxy-1,1 diphosphonate (EHDP) at a low dosage (5 mg/kg/day).
April 1983, Clinical orthopaedics and related research,
G Chabrier, and C Simon, and J L Schlienger, and M Imler
[Neoplastic hypercalcemia with renal insufficiency: treatment with dichloromethylene diphosphonate].
November 1985, La Clinica terapeutica,
G Chabrier, and C Simon, and J L Schlienger, and M Imler
Effects of dichloromethylene diphosphonate, ethane-1-hydroxy-1,1-diphosphonate, and rickets in rats.
November 1975, The Journal of laboratory and clinical medicine,
G Chabrier, and C Simon, and J L Schlienger, and M Imler
[Treatment of neoplastic hypercalcemia using single-infusion diphosphonate].
January 1988, Schweizerische medizinische Wochenschrift,
G Chabrier, and C Simon, and J L Schlienger, and M Imler
Proceedings: Treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1,1-diphosphonate.
March 1975, The Journal of endocrinology,
G Chabrier, and C Simon, and J L Schlienger, and M Imler
Letter: Disodium ethane-1-hydroxy-1, 1-diphosphonate(E.H.D.P.) in Paget's disease.
October 1975, Lancet (London, England),
G Chabrier, and C Simon, and J L Schlienger, and M Imler
Effect of disodium ethane-1-hydroxy-1, 1-diphosphonate on bone formation.
January 1971, Clinical orthopaedics and related research,
G Chabrier, and C Simon, and J L Schlienger, and M Imler
Effects of ethane-1-hydroxy-1, 1 diphosphonate on Dunn osteosarcoma cells.
March 1997, Journal of experimental & clinical cancer research : CR,
Copied contents to your clipboard!